Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

92 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-31

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The rapid and accurate detection of influenza virus in respiratory specimens is required for optimal management of patients with acute respiratory infections. Because of the variability of the symptoms and the numerous other causes of influenza-like illness, the diagnosis of influenza cannot be made on the basis of clinical criteria alone. Thus, rapid influenza diagnostic tests have been developed such as the Alere i Influenza A\&B isothermal nucleic acid assay. Investigators prospectively evaluated the performance of the Alere i Influenza A\&B assay in comparison with the routine Xpert Flu/RSV assay.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Influenza A+B Test Kit Performance Study

NCT03895268

Influenza Type A Influenza Type B

UNKNOWN

Influenza Diagnosis, Treatment and Surveillance With Xpert Flu

NCT01947049

Influenza

COMPLETED NA

Influenza Challenge Study in Healthy Volunteers

NCT02746211

Influenza

COMPLETED PHASE1/PHASE2

A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects

NCT02037282

Influenza Flu

WITHDRAWN PHASE1

Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B

NCT01753531

Influenza, Human

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Main objective / secondary:

It appears that so far the weight of the influenza disease, the limits of clinical diagnosis and validity of rapid diagnostic methods to emergencies are well studied and validated. However the potential organizational and economic benefit in emergency care services remains little known and rarely evaluated.

The significant improvement in diagnostic response time he has a real beneficial impact for the patient? For the organization of the emergency? Investigators propose to study the impact of the implementation of rapid diagnostic solution by molecular biology of influenza directly available in an adult emergency department, from a cohort of patients consulting in connection a flu-like illness. Investigators wish in particular to highlight the organizational and economic impact.

Methodology :

DESIGN:

Study single-center, prospective, descriptive, observational, type "before / after".

Unable to reasonably perform a prospective randomized study due to the constraints for patients and for the service and means that it would be necessary to deploy in this case (CRA ... PHRC), Methodology :

DESIGN:

Study single-center, prospective, descriptive, observational, type "before / after".

Unable to reasonably perform a prospective randomized study due to the constraints for patients and for the service and means that it would be necessary to deploy in this case (CRA ... PHRC), we are moving more towards a comparison study before / after between February and April.

Time study Total study duration: 3 months Inclusion period: 3 months (February 2016- April 2016)

Acquisition of data:

Data Observing Notebook (CRF or "Case Report Form") are disclosed in the notes accompanying this document and will be collected aur an Excel spreadsheet Statistical analysis ( For each subject will be awarded an identifier (original name and surname - year of birth) and the data will be entered on a computer file which will be sent to the statistician in charge of analyzing the GHPSJ site. There will be no exchange of personal data for this study is single center on the site GHPSJ.

Development of the study:

The patient presents to the Emergency Home Service for a "flu syndrome". During the first phase ( "before"), the assumption will be that usually achieved.

During the second phase ( "after"), a flu test is routinely performed within the home emergency department by the doctor who supports the patient.

In both cases, the doctor continues to support according to information it has and according to good practice and service protocols.

A case report form (CRF or Case Report Form) is completed for each patient included in the study. This report forms includes a questionnaire that collects anonymous demographic information (patient age and sex) and clinical data. The CRF also includes the results of the rapid test for influenza. These notebooks anonymous comments are seized by the Home Emergency Service on a type of database "Access" (which will then be completed by the results of the rapid test. If positive, strain characterization will be clarified.

Number of patients recruited (justification) and duration of participation for each patient:

Not applicable as observational study are moving more towards a comparison study before / after between February and April.

Time study Total study duration: 3 months Inclusion period: 3 months (February 2016- April 2016)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group with support that will be usually performed

During the first phase ("before"), the assumption will be that usually achieved.

The doctor continues to support according to information it has and according to good practice and service protocols.

No interventions assigned to this group

Group with a flu test

During the second phase ("after"), a flu test is routinely performed within the home emergency department by the doctor who supports the patient.

The doctor continues to support according to information it has and according to good practice and service protocols.

Flu Test

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Flu Test

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Respiratory Symptoms include cough, dyspnea and / or
2. General symptoms: headache, myalgia, asthenia, anorexia ... and / or
3. Acute fever above 38 ° C
4. Patient consent.

Exclusion Criteria

* Major cognitive disorders
* Patient under guardianship
* Patient refusing to consent to research
* Duplicate (patients who have had laboratory diagnosis of influenza in previous 7 days)
* Patient not receiving social security

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No